Jain Rita Insider Trades

Insider Trading History

Track insider trading activity for Jain Rita. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $18.4k 1,339 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 1,339 shares
$14.93
$13.74
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $282k 5,500 shares
Last Trade
Jan 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 9,500 shares
$43.91
$51.24
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $806k 240,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 240,000 shares
$3.74
$3.36
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $4.03k 240,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.78k 240,000 shares
$0.03
$0.02
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $14.3k 1,043 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9k 1,043 shares
$18.16
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $21.6k 1,572 shares
Last Trade
Sep 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 1,572 shares
$12.71
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $552k 40,200 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 40,200 shares
$4.47
$13.74
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $608k 11,864 shares
Last Trade
Jun 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 7,330 shares
$23.32
$51.24
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $491k 16,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$322k 16,500 shares
$19.53
$29.77
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $846k 16,510 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 16,510 shares
$14.83
$51.24
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $0 0 shares
Last Trade
Jun 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30.9k 1,300 shares
$23.77
$51.24
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $232k 4,534 shares
Last Trade
Jun 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 4,534 shares
$23.77
$51.24
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $491k 16,500 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$601k 16,500 shares
$36.43
$29.77
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $846k 16,510 shares
Last Trade
Jan 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 16,510 shares
$21.19
$51.24
Provention Bio
Provention Bio PRVB
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.65M 66,000 shares
$24.98
$24.98
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $543k 10,600 shares
Last Trade
Apr 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$411k 18,615 shares
$22.09
$51.24
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $509k 17,100 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$724k 17,100 shares
$42.34
$29.77
Provention Bio
Provention Bio PRVB
Director
Holding Value $1.65M 66,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$638k 66,000 shares
$9.67
$24.98
ChemoCentryx
ChemoCentryx CCXI
Evp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Oct 20, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$603k 11,600 shares
$51.99
$10.24
ChemoCentryx
ChemoCentryx CCXI
Evp, Chief Medical Officer
Holding Value $0 0 shares
Last Trade
May 20, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$176k 7,726 shares
$22.79
$10.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up